Publication | Closed Access

The effect on bone mass and bone markers of different doses of ibandronate: A new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: A 1-year, randomized, double-blind, placebo-controlled dose-finding study

Bone MarkersOrthopaedicsBone MassBone DensityNew BisphosphonateMedicineOsteoporosisBone Metabolism